Mayo Clinic Laboratory and Pathology Research Roundup: December 12 - Insights
This week's research roundup feature: Most patients with solitary bone plasmacytomas (SBP) progress to multiple myeloma (MM) after definitive radiation therapy as their primary treatment. Whether the presence of high-risk (HR) cytogenetic...
People Archives - Page 34 of 35 - Insights
Skip to Content MayoACCESS MayoLINK...
One Test, Multiple Targets: Zeroing in on Autoimmune Movement Disorders - Insights
A movement disorder might be caused by the body’s immune system, which is meant to fight infections, suddenly attacking the brain. Fortunately, an “autoimmune movement disorder” can often be treated—once its cause is discovered.
Elevating accuracy of Alzheimer's testing - Insights
Learn how Mayo Clinic Laboratories Alzheimer’s disease testing provides clearer answers for more patients by offering the highest level of overall accuracy for the detection of amyloid pathology.
Uptick in Vector-Borne Illnesses in U.S. and What It Means to You - Insights
Illnesses caused by disease-infected ticks, mosquitoes, and fleas have tripled in the U.S. in recent years, according to a new report from the Centers for Disease Control and Prevention. Lyme disease is the most common illness attributed to...
CPT codes and LOINC update: December 2021 - Insights
CPT code updates posted to mayocliniclabs.com during the month of December.
What's Next in Precision Medicine: Moving New Discoveries into Daily Clinical Care - Insights
Experts in individualized medicine—the concept of shaping health care based on lifestyle, environment, and genetic code—will be in Rochester September 12–13 to present how the newest discoveries can be applied to personalized health care.
Mayo Clinic released a new DNA product with Helix, a personal genomics company, called "Mayo Clinic GeneGuide." The DNA-powered product provides healthy individuals with genetic testing and insights with a focus on education.
Mayo Clinic Research Advances Diagnostics to Lead COVID-19 Pandemic Response - Insights
When COVID-19 spread across the U.S. in early March, Mayo Clinic’s Advanced Diagnostic Laboratory urgently responded.
Mayo Clinic Researchers Find New Way to Improve Newborn Screening of Pompe Disease - Insights
Researchers at Mayo Clinic have discovered a second-tier test for Pompe disease that has been shown to improve the specificity of newborn screening for the disorder, which would lower the rate of false-positive results.